Apixio raises $19.3M in Series D

What does Apixio do?
Apixio, is a data science company for healthcare. The company’s HCC Profiler enables health systems and insurers in more efficiently and accurately reviewing their medical coding, correcting inaccuracies and gaps, improving financial reporting and delivering good quality care. It is built on a very advanced cognitive computing platform which helps in extracting knowledge from unstructured clinical data.
How much Apixio was funded?
The company raised $19.3M in Series D on May 24, 2016 from First Analysis,  SSM Partners and Bain Capital Ventures.
Previous funding
$2.79M in Series A on March 23, 2011 from Farzad (Zod) Nazem
$501.25k in Series A on December 30, 2009
$5.79M in undisclosed round on August 16, 2012
$13.5M in Series C on May 27, 2014 Bain Capital Ventures, Farzad (Zod) Nazem
What is next for Apixio?
The company plans on using the latest funding raised to advance and scale products powered by its cognitive computing platform and to further enable insghts of its optimal patient care. The latest funding comes as the company experiences strong demand and momentum for its HCC Profiler solution, which finds unstructured medical records, for an better and accurate view of the chronic conditions of patients, so that the providers and payers can provide better care.
More about Apixio
Apixio was founded in 2009 by Imran Chaudhri, Shahin Hedayat and Shawn Dastmalchi. The company powered by its cognitive computing platform brings advanced data to healthcare by analyzing and extracting previously mined unstructured medical record data, providing healthcare payers and providers access to insight into the patient’s chronic conditions. The company’s platform is built on the inishgts of analyzing over 6 M patients’ charts. Its HCC Profiler enables more targeted care delivery and helps the Medicare payers and provider payment for Medicare Advantage enrollees, powering high quality and cost effective care. The company was founded with the idea of leveraging big data analytics for reducing the healthcare costs and improving the quality of care.